Savolitinib
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for Savolitinib, covering 2017-10-26 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment [Phase 3]